Assessment of a Novel Sound-based Treatment for Managing Distress Related to Tinnitus
Sponsored by Toronto Metropolitan University
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Pure-Tone Average hearing loss (500, 1000, 2000, 4000) of 30 decibels hearing loss or greater in the better ear.
- Tinnitus Handicap Index scores of 18 to 76 (mild to severe handicap).
- Self-report of chronic, non-intermittent tinnitus experienced > 3 months
Exclusion Criteria
- Adults younger than 50 years old, or adults older than 80 years old.
- Pulsatile tinnitus (tinnitus that modulates synchronously with a participant's pulse)
- >20 dB HL difference in pure-tone average between ears
- > 80 dB HL PTA averaged across ears
- Individuals currently undergoing other tinnitus treatment programs will not be able to participate in our study. This is to ensure that our findings are accurately attributed to our App and not influenced by external factors. If someone is already receiving treatment for their tinnitus, it would be challenging to distinguish the effects of our App from their existing treatment regimen. To eliminate the possibility of such confounding factors, our team kindly asks participants to disclose if they are undergoing other treatments for tinnitus.